Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERLIN: ART Timing and Alcohol in Early HIV
NCT02744040Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Aug 2017
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Open-label trial in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fred Hutchinson Cancer Center. Primary endpoints: Total HIV DNA Reservoir at 4 years, Integrated HIV DNA Reservoir at 4 years and 8 more. Started Aug 2017; status: completed.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02744040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744040.